Occudo Quantitative Strategies LP Agenus Inc Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $16,031 - $23,672	-6,822 Reduced 11.01%	55,163 $136,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $70,772 - $139,120	24,237 Added 64.21%	61,985 $200,000
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $187,985 - $250,269	37,748 New	37,748 $198,000
Q1 2021 May 14, 2021	SELL	$2.69 - $5.25 $81,103 - $158,287	-30,150 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.17 - $4.49 $95,575 - $135,373	30,150 New	30,150 $96,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.